Efficacy and safety of a two-step method of skin preparation for peripheral intravenous catheter insertion: a prospective multi-centre randomised trial by van der Mee-Marquet, Nathalie L
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Anesthesiology
Open Access Research article
Efficacy and safety of a two-step method of skin preparation for 
peripheral intravenous catheter insertion: a prospective 
multi-centre randomised trial
Nathalie L van der Mee-Marquet* and the Bloodstream infection Study Group 
of the Relais Régional d'Hygiène Hospitalière du Centre
Address: Service de Bactériologie et d'Hygiène, Hôpital Trousseau, Centre Hospitalier Universitaire, 37044 Tours, France
Email: Nathalie L van der Mee-Marquet* - n.vandermee@chu-tours.fr; the Bloodstream infection Study Group of the Relais Régional d'Hygiène 
Hospitalière du Centre - secretariat.rhc@chu-tours.fr
* Corresponding author    
Abstract
We have developed a two-step procedure for preparing the skin before peripheral venous catheter
(PVC) insertions. This procedure involves two successive swabbings with wipes soaked in alcoholic
antiseptic. We investigated whether this two-step procedure was as effective and safe as the
standard four-step procedure – washing with detergent, rinsing, drying, applying antiseptic – by
carrying out a multicentre randomised equivalence study comparing the frequency of precursor
signs of infection at the site of insertion for the two skin preparation procedures. The study was
carried out over an eight-month period, and 248 PVC insertion sites were evaluated. The two-step
procedure was used for 130 subjects and the standard procedure for 118. Taking into account all
the confounding factors predisposing patients to the complications studied, the characteristics of
the two groups of patients were found to be similar, with no significant differences noted. The
incidence of precursor signs of infection was 11 % 24 hours after PVC insertion (27/248), 25 % at
48 hours (50/203) and at 29 % at 72 hours (34/119). Eleven patients had complications necessitating
the withdrawal of the PVC: sensitivity of the insertion site, with redness and/or slight swelling and/
or a palpable venous cord. No major complications were observed in this study. The frequency of
local complications associated with PVCs reported in this study, whether simple or severe, was not
affected by the skin preparation procedure used for PVC insertion (two-step or four-step
procedure).
Background
Peripheral venous catheters (PVCs) are frequently used in
hospitalised patients. The insertion of a PVC is an invasive
act that may lead to local complications, thrombophlebi-
tis, and infection of the PVC, which may cause bacterae-
mia or fungaemia [1-3]. Bacteraemia associated with the
use of PVCs is rare (<0.1 to 0.2%) [1], but the high fre-
quency of PVC use nonetheless results in high morbidity
levels. The risk factors for complications associated with
the use of PVCs relate to the patient (age, sex, associated
disease, nearby infectious focus), the catheter (type of
material, size), its insertion and the care administered
(site of insertion, experience of the healthcare worker, lack
of asepsis, duration of catheterisation, number of inter-
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ventions involving the PVC, quality of maintenance of the
device) and the solutes perfused (composition, pH, osmo-
larity, infusion rate) [2-8]. Most of the complications
associated with the use of PVCs are avoidable [9]. Their
prevention is based on good hand hygiene before inser-
tion and during maintenance, choice of insertion site, the
use of aseptic techniques for insertion and manipulation
of the catheter, catheter attachment and limitation of the
use of hypo- and hypertonic solutions [1,10-15].
We have developed a two-step procedure for skin prepara-
tion before the insertion of PVCs, involving two successive
swabbings with wipes soaked with alcoholic antiseptic.
We carried out a multicentre study comparing this two-
step procedure with a standard four-step procedure –
washing with detergent, rinsing, drying, application of
antiseptic – to determine whether the two procedures
were equally effective and safe.
Materials and methods
Design of study
The Relais Régional d'Hygiène Hospitalière du Centre (RHC),
the centre responsible for monitoring nosocomial infec-
tions in the Centre Region of France (2.5 million inhabit-
ants), aims to decrease the risk of infection associated
with the use of intravenous devices. In 2004, we asked
healthcare centres of the OUEST inter-region of France to
participate in a multi-centre equivalence study, stratified
by centre and comparing, in parallel, two skin preparation
procedures for PVC insertion: a two-step procedure (A)
and the standard four-step procedure (B). The study was
co-ordinated by the RHC, the staff of which wrote the
study protocol, trained the investigators, prepared ran-
domisation lists entered and analysed data from the
observation notebooks. Ethical approval of the trial was
obtained from the Scientific Council of the CCLIN Ouest
and Current Controlled Trials has assigned the following
ISRCTN to the trial : ISRCTN01075518.
Twelve healthcare institutions (11 hospitals and clinics,
one long-term care centre) participated in this study,
which was carried out between February 1st and August
31st 2004. In each participating centre, two groups of
patients were selected, randomised and stratified by centre
(group A treated with procedure A, group B with proce-
dure B). The investigators informed the heads of nursing
care in their institutions, informed and trained health
managers and nurses, centralised the randomisation list,
attributed each patient to a skin preparation procedure
group on inclusion, monitored the running of the study
and collected the results for their centres.
Inclusion of patients
The investigators were responsible for including patients
in the study. This involved asking eligible patients to par-
ticipate, providing information about the protocol, pre-
senting the letter of information and the consent form
and collecting the consent form after the patient had been
allowed time to consider their participation, preparing an
observation notebook, randomising skin preparation pro-
tocols and noting the prescription on the data collection
form, with randomisation. The inclusion criteria were as
follows: hospitalised, consenting adults aged over 18
years, male or female, requiring the insertion of a contin-
uous PVC with a treatment duration of more than 48
hours, and those for whom either skin preparation proce-
dure could be used. The non-inclusion criteria were med-
ical reasons, the insertion of a catheter for emergency
perfusion, allergy to povidone, a planned intravenous
treatment time of less than 48 h, the presence of skin
lesions at the chosen insertion site, being in the last three
months of pregnancy, refusal to give consent, patient
unconscious or incapable of understanding the informa-
tion given. The number of subjects required for this equiv-
alence study was estimated at 231 subjects per group,
assuming a frequency of pre-infection signs of 25 to 30%,
and a difference of 5% between the frequencies in the two
groups for equivalence of the two techniques of skin prep-
aration and a study power of 80% (Nquery software).
The two procedures of skin preparation
Procedures A and B are described in table 1. Povidone
iodine is a first-line antiseptic with prolonged activity and
alcohol is a fast-acting antiseptic routinely used to disin-
fect injection sites. The use of an antiseptic in alcoholic
solution results in rapid, strong and persistent bactericidal
activity, with more rapid drying than for aqueous solu-
tions. Povidone iodine in ethanol (Bétadine®, 5% povi-
done iodine in ethanol), which is used for skin
disinfection before surgery [16], was chosen for this pro-
cedure. Procedure B involved the use of a detergent solu-
tion (Bétadine Scrub®, povidone iodine), sterile water
(injectable, 10 ml ampoule) and an antiseptic (Bétadine
Dermique®, 10% povidone iodine). The choice of product
was based on authorisation for market release for PVC
insertion, knowledge of application times and packaging
in 10 ml single-use containers, facilitating their use in this
study. The RHC provided the participating institutions
with these products and the departments within the insti-
tutions were supplied with the products by their pharma-
cists.
Insertion of catheters
PVCs were inserted and maintained by nursing staff. The
investigators were responsible for checking that the pre-
scribed skin preparation protocol was adhered to and for
collecting data concerning possible confounding factors.
These included the age of the patient, immunosuppres-
sion, nature of the catheter, number of manipulations perBMC Anesthesiology 2007, 7:1 http://www.biomedcentral.com/1471-2253/7/1
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day, duration of catheterisation and the nature of the per-
fused solutes.
Evaluation of the appearance of precursor signs of 
infection at the insertion site
The ideal way to determine whether the two-step proce-
dure was as effective and safe as the standard four-step
procedure would have been to compare the incidence of
infections linked to PVCs as a function of skin preparation
procedure. However, this would have required a much
larger series of patients, which would be difficult to
achieve nowadays in a context of medical wards with
overworked staff. Observations of precursor signs of infec-
tions associated with PVCs, and comparisons of their fre-
quency as a function of certain criteria (nature of the
catheter, antiseptic used, insertion site, etc.) have been
used to study the risk factors for PVC-linked infections
[4,14,17]. We therefore carried out a randomised equiva-
lence study, comparing the frequency of precursor signs of
infection at the site of insertion for the two skin prepara-
tion procedures.
Inspection of the insertion site is a key part of nursing
care. Patients were monitored daily throughout the time
of perfusion, until withdrawal of the catheter, for a maxi-
mum of 72 h. The judgement criterion was the appearance
of precursor signs of infection at the insertion site, as eval-
uated according to the Maddox scale (detailed in table 2)
[17]. The nurses were trained in the use of this scale before
the start of the study. The indications for catheter removal
were evaluated each day. Catheters that were no longer
required were removed. Catheters were also systematically
removed if major precursor signs of infection were
observed.
Data analysis
We began by describing the study sample, to check that
groups A and B were comparable in terms of confounding
factors. The principal analysis then involved comparing
the frequency of precursor signs of infection in the two
groups. The judgement criterion was a qualitative, six-
class (0–5) variable for each group of subjects. We there-
fore calculated the percentage and confidence interval for
each class and compared the percentages between groups
by means of a χ2 test with five degrees of freedom. The sec-
ondary analyses, with adjustment for potential confound-
ing factors, were then carried out.
Results
The study was initially planned to run for six months and
required meticulous, fastidious and committed work
from the investigators, particularly as it was necessary to
seek the patients' consent. Despite a two-month prolonga-
tion, and due to the difficulties encountered in trying to
recruit patients, the planned number of patients was not
reach and the final analysis was based on only 248 files.
Insertion of catheters
We evaluated 248 PVC insertion sites for early signs of
infection. The number of cases included in each centre
varied from 2 to 54 (median value 14). Procedure A was
carried out for 130 subjects and procedure B, for 118. The
characteristics of the patients and the confounding factors
are presented in table 3. Taking into account all the con-
founding factors predisposing patients to the complica-
tions studied, the characteristics of the two groups of
patients were found to be similar, with no significant dif-
ferences noted.
Incidence of complications and association with the skin 
preparation procedure
In total, 811 insertion site inspections were carried out: 45
PVCs were evaluated on a single occasion, because they
were removed within 48 hours, 84 PVCs were evaluated
on two occasions and were removed within 72 hours, and
the remaining 119 PVCs were evaluated on three occa-
sions and removed after 72 hours in place. The incidence
of complications in the two groups, as evaluated by the
Maddox index [17], is shown in table 4. The results are
expressed as a function of duration of catheterisation,
with three groups, corresponding to patients with PVCs in
place for up to 24 hours, 48 hours and 72 hours. The over-
all incidence of precursor signs of infection was low in
both groups for a catheterisation for up to 24 hours, with
Table 1: Details of the two-step procedure (A) and the standard four-step procedure (B)
Two-step procedure (A) Standard four-step procedure (B)
Products Alcoholic antiseptic solution [Bétadine® 5 % in alcohol, iodine 
antiseptic]
Detergent solution [Bétadine® Scrub, povidone iodine]
Sterile water [injectable, 10 ml ampoule] Antiseptic solution 
[Bétadine® Dermique 10% in alcohol, povidone-iodine]
Procedure Extensive application of the alcoholic antiseptic with sterile 
wipes.
Skin left to dry in air for 30 seconds
Second application of alcoholic antiseptic with a fresh sterile 
wipe.
Skin left to dry in air for 30 seconds before insertion of the 
PVC
Application of the foaming detergent solution. Rinsing, with sterile 
compresses imbibed with sterile water.
Drying with sterile compresses.
Application of antiseptic, using sterile compresses imbibed with the 
product.
Skin left to dry in air for 1 minute before insertion of the PVC.BMC Anesthesiology 2007, 7:1 http://www.biomedcentral.com/1471-2253/7/1
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89 % (221/248) of patients having no complications
(Maddox index = 0). Complications were observed in 50
of the 203 (25 %) patients with PVCs in place for up to 48
hours, and in 34 of the 119 (29 %) patients with PVCs in
place for 72 hours. Eleven patients had severe complica-
tions (Maddox index 3 and 4). The PCV was withdrawn in
each of these 11 cases. The largest number of severe com-
plications (4 of 63) occurred in patients with procedure A
skin preparation and PVCs left in place for 72 hours. How-
ever, the actual numbers were so small that they did not
differ significantly from those for group B. No major com-
plications (Maddox index 5) were observed in this study.
The frequency of complications, whether simple or severe,
did not differ significantly between groups A and B.
Frequency of complications and risk factors
The precursor signs of infections in both groups (A and B)
associated with the various known risk factors are listed in
table 5. For all studied risk factors, no significant differ-
ences could be seen between the groups.
Skin tolerance and alcoholic antiseptics
Alcoholic antiseptics have been reported to cause chemi-
cal burns in some cases [18]. The investigators were asked
to note any abnormalities. No skin reaction was reported
during the study in patients from either of the two groups.
Discussion
The insertion site of the catheter is the principal source of
PVC contamination, and the density of the skin micro-
Table 3: Characteristics of the patients of groups A and B as a function of confounding factors
Number of patients p*
Total By procedure
AB
Number of PVCs 248 130 118
Sex ratio (M/F) 155/93 84/46 71/47 0.47
Age > 70 years 88 42 46 0.27
Immunosuppression 62 32 30 0.88
Insertion site
Back of the hand 35 20 15 0.91
Elbow 17 8 9
Forearm 190 99 91
O t h e r 633
Nature of the PVC
Polyurethane 150 79 71 0.79
Polyvinyl chloride 57 28 29
Teflon 41 23 18
Duration of catheterisation
> 24 h and < 48 h 248 130 118 0.87
> 48 h and < 72 h 203 108 95
72 h 119 63 56
Mean duration > 48 h and < 72 h > 48 h and < 72 h > 48 h and < 72 h
No. manipulations > 4/day 52 29 23 0.58
Solutes perfused
A n t i b i o t i c s 8 54 54 0 0 . 9 0
Anticancer drugs 57 30 27 0.97
Lipids 9 5 4 0.85
Blood products 7 5 2 0.31
*Chi squared was calculated with values obtained for groups A and B.
Table 2: The Maddox scale
Index Complications Clinical signs
0 None No signs
1 Simple Sensitivity or redness at the insertion site
2 Simple Sensitivity of the insertion site, with redness or slight swelling
3 Severe Sensitivity of the insertion site, with redness and slight swelling or a palpable venous cord
4 Severe Sensitivity of the insertion site, with redness, slight swelling and a palpable venous cord
5 Major All the signs listed for index 4 plus purulenceBMC Anesthesiology 2007, 7:1 http://www.biomedcentral.com/1471-2253/7/1
Page 5 of 8
(page number not for citation purposes)
flora at the insertion site is a major risk factor for PVC-
linked bacteraemia [3,8,19]. Strict compliance with skin
preparation procedures before insertion of the PVC is one
of the principal means of preventing PVC-linked infection
[20]. The American Centers for Disease Control (CDC)
recommend the disinfection of clean skin with an appro-
priate antiseptic, using a sufficiently long contact time and
allowing the skin to dry in the air before inserting the
catheter [15]. The French guidelines recommend the use
of two products (a detergent and an antiseptic) in four
steps (washing with detergent, rinsing, drying, application
of antiseptic) for skin preparation [21].
A lack of training, underestimation of the risk of compli-
cations associated with the use of PVCs and a too-heavy
workload often result in poor adherence with procedures
for PVC insertion in routine practice [10,11,22,23]. In
2002, an audit of skin preparation before the insertion of
PVCs carried out in six healthcare institutions in the Cen-
tre region of France showed a large gulf between theory
and practice, with compliance with the recommended
skin preparation techniques observed in only 30% of the
105 observations. This lack of compliance was attributed
to the time-consuming nature of the recommended proce-
dure. We therefore developed a two-step skin preparation
procedure, with the aim of increasing compliance with
disinfection procedures by simplifying the technique.
The two-step procedure involves two successive swab-
bings with wipes soaked in alcoholic antiseptic. As alco-
hol is an efficient solvent, the first swabbing replaces
washing with detergent. The rapid biocidal activity of the
alcohol, together with that of the antiseptic, starts to
decrease the bacterial load immediately. As the alcoholic
antiseptic, unlike detergent, does not generate an emul-
sion of organic matter, rinsing is unnecessary, and the vol-
atility of the alcohol facilitates the rapid drying of the skin
without the need for wiping. The second swabbing corre-
sponds to the true antiseptic step.
A large number of patients would have been required to
demonstrate equivalent efficacy and safety of the two
methods by comparing the incidence of PVC-linked infec-
tions as a function of skin preparation procedure, because
the incidence of bloodstream infections related to PVCs is
low. Thrombophlebitis is a precursor sign of PVC infec-
tion and has been reported to occur after 24 hours in 12
to 34% of cases and after 48 hours in 36 to 65% of cases
[6,11,16,17]. The observation of precursor signs of infec-
tion associated with PVCs, and the comparison of their
frequency as a function of certain criteria has been used to
evaluate risk factors for PVC-linked infections in several
previous studies. A prospective double-blind study of 195
men evaluated the effect of inline intravenous filters on
post-infusion thrombophlebitis and the bacterial coloni-
sation of catheters [24]. A comparative study of different
skin preparation methods for PVCs was conducted in 60
patients, with monitoring of the incidence of precursor
signs of infection as a function of skin preparation meth-
ods [14]. Another study compared peripheral intravenous
Teflon® and Vialon® catheters [4], assessing the incidence
of thrombophlebitis for 170 PVCs. Based on these data,
we carried out our randomised equivalence study compar-
ing the frequency of precursor signs of infection at the site
of insertion for the two procedures: the two-step proce-
dure and the standard four-step procedure.
The 111 complications reported – 100 simple and 11
severe – highlight the necessity of strict indications for the
use of PVCs, to limit the occurrence of incidents and acci-
dents caused by the use of these devices. The frequency of
precursor signs of infection associated with PVCs in our
Table 4: Early signs of infection, evaluated by the Maddox index, as a function of the skin preparation procedure used
No. of insertion site observations (%)
24 hours after insertion 48 hours after insertion 72 hours after insertion
By procedure
Maddox index A (n = 130) B (n = 116) A (n = 109) B (n = 94) A (n = 63) B (n = 56)
0 112 (86%) 107 (92%) 81 (74%) 72 (77%) 44 (70%) 41 (73%)
1 Simple 12 7 19 12 11 12
2 Simple 5 3 7 8 4 2
Total – simple 17 (13%) 10 (9%) 26 (24%) 20 (21%) 15 (24%) 14 (25%)
3 Severe 0 1 2 1 1 0
4 Severe 1 0 0 1 3 1
Total – severe 1 (<1%) 1(<1%) 2 (2%) 2 (2%) 4 (6%) 1 (2%)
5 Major 0 0 0 0 0 0
Number of PVCs with precursor signs of infections 18 (14%) 9 (8%) 28 (26%) 22 (23%) 19 (30%) 15 (27%)
27 (11%) 50 (25%) 34 (29%)
p* 0.127 0.706 0.684
*Chi squared was calculated for numbers of PVCs displaying precursor signs of infections in groups A and B.BMC Anesthesiology 2007, 7:1 http://www.biomedcentral.com/1471-2253/7/1
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study was lower than that reported in previous studies
[17], probably because of the care taken to ensure that
skin preparation procedures were followed during the
study. No bacteraemic infections were observed for any of
the 248 PVCs, probably as a consequence of the small
sample size and the immediate withdrawal of the 11 PVCs
for which severe complications were observed.
In conclusion, the frequency of precursor signs of infec-
tion associated with PVCs reported in this study was not
affected by the skin preparation procedure used for PVC
insertion (two-step or four-step procedure). Despite the
limitations of our study (due to fewer patients than
intended being recruited), the two-step procedure appears
to be as safe and effect a method of skin preparation for
PVC insertion as the standard four-step method.
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